Civil Litigation
Jul. 18, 2019
Plaintiffs seek consolidation of suits against Gilead over HIV drugs
A federal judge is set to hear arguments this month on whether 17 personal injury cases against pharmaceutical giant Gilead Sciences Inc. will be consolidated in a case alleging the company withheld from the market a better HIV drug so they could sell a more expensive one.
A federal judge is set to hear arguments this month on whether 19 personal injury cases against pharmaceutical giant Gilead Sciences Inc. will be consolidated in a case alleging the company withheld from the market a better HIV drug so they could sell a more expensive one.
Elizabeth Graham, a director of Grant & Eisenhofer PA's complex pharmaceutical litigation practice, said she believes there is a high likelihood of consolida...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
